Is FRLN stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Freeline Therapeutics 10 years ago, but if you had invested on Friday 7th of August 2020 when the price was $270.00, you would have made a loss of $-263.52 per share or -97.60%
No, the average daily trading liquidity for Freeline Therapeutics is $258 673 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Freeline Therapeutics has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Freeline Therapeutics to be medium [0.7 out of 1]